ISRCTN61727489已完成3 期
A Phase III study of radical radiotherapy with or without gemcitabine in patients with T1-2 N0-1 M0 non-small cell lung cancer
niversity of Edinburgh (UK)0 个研究点目标入组 0 人开始时间: 2002年10月15日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
2012 results in: http://www.ncbi.nlm.nih.gov/pubmed/22672970
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histological or cytological diagnosis of T1-2 N0-1 M0 NSCLC in patients deemed unfit for resection in the opinion of the thoracic surgeon
- •2. No prior chemotherapy or radiotherapy for the treatment of NSCLC
- •3. Performance status 0-2 on the Zubrod scale 4. Estimated life expectance at least 12 weeks
- •5. <10% weight loss in the year preceding randomisation
- •6. Patient compliance and geographic proximity allowing adequate follow-up
- •7. Adequate bone marrow reserve
- •8. Adequate respiratory function
- •9. Radiologically measurable or non-measurable lesion
- •10. Aged at least 18 years
- •11. Written informed consent
- •12. Effective contraception (where appropriate) during and for at least 3 months following the trial
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
A Phase III Study of Radiotherapy or ABVD Plus Radiotherapy Versus ABVD Alone in the Treatment of Early Stage Hodgkin's DiseaseCancerISRCTN94798326ational Cancer Institute of Canada Clinical Trials Group (NCIC CTG)405
已完成
不适用
Radiotherapy (intensity-modulated radiation therapy [IMRT]), Erbitux® And CHemotherapy for unresectable carcinomas of head and necknresectable carcinomas of head and neckMalignant neoplasm of other and ill-defined sitesCancerISRCTN87356938niversity of Heidelberg (Germany)60
进行中（未招募）
不适用
PEARLS - a trial of radiotherapy in newly-diagnosed patients with lymph node positive prostate cancerMalignant neoplasm of prostateCancerProstate CancerISRCTN36344989Institute of Cancer Research893
已完成
3 期
A multicentre randomised trial of radical radiotherapy with carbogen in the radical radiotherapy of locally advanced bladder cancerBladder (advanced)BladderCancerISRCTN45938399Cancer Research UK (CRUK) (UK)
进行中（未招募）
3 期
Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell CarcinomaNCT02025036The First Affiliated Hospital of Henan University of Science and Technology249